Collection and Analysis of Imported Frozen Seafood for Economically Motivated Adulteration
Introduction | Background | Methodology
Findings| Follow-Up Actions | Discussion
Table of Analytical Results | Related Resources
Introduction
As part of the U.S. Food and Drug Administration’s (FDA) continued efforts to fight economically motivated adulteration, the agency conducted an assignment in 2025 to collect and test imported frozen raw and cooked seafood products for short weighting (i.e., foods offered for sale that contain less than the declared net weight on the package). Short weighting in frozen seafood can occur if the product’s net weight includes the weight of the ice glaze.1
Economically motivated adulteration is the regulatory term used by the FDA for food fraud. It refers to the substitution, addition, or omission of a substance in a product, or concealment of its inferiority or damage to increase its apparent value or reduce the cost of production (i.e., for economic gain). Simply put, it’s an effort to cheat consumers.
The FDA’s mission centers on protecting the public health; however, the agency also is charged to safeguard consumers against economic adulteration in foods. The agency generally prioritizes the collection and testing of foods at high risk for economic adulteration, including honey, juice, olive oil, seafood, and spices, among other products, as described on FDA.gov.
Background
It is common industry practice to add ice glaze to frozen seafood products to help protect them from freezer burn during extended storage. The longer a product may be frozen, the thicker the typical glaze may be. However, overstating the net weight of frozen seafood by including the weight of the ice glaze is prohibited under the Federal Food Drug and Cosmetic Act (FD&C Act). 2
The FDA’s Guidance for Industry: 1991 Letter to Seafood Manufacturers Regarding the Fraudulent Practice of Including Glaze (ice) as Part of the Weight of Frozen Seafood explains how the inclusion of the glaze weight as part of the product net weight can cheat consumers out of the fair value of their purchase.
From 2022 to 2024, the FDA conducted an assignment, similar to the one presented in this sampling report, to collect and test imported frozen raw and cooked seafood products for short weighting. Of the 28 samples analyzed, 10 samples (36%) were found to be violative, with percent short weighting ranging from 2.3% to 9.9% below the declared net weight on the package. However, unlike the FDA’s 2025 assignment, the 2022-2024 assignment was partially targeted3 by design given that the agency had received complaints that certain firms were short weighting their frozen seafood products.
The goals of the FDA’s 2025 assignment were to identify imported packaged frozen seafood products violative for short weighting and to prevent adulterated and/or misbranded products from being distributed in the U.S. market.
Methodology
During the 2025 assignment, the FDA collected and tested 26 samples of imported packaged frozen seafood products (i.e., in retail packages) to determine whether they met the net weight declared on the product label without the glaze. The 26 samples (21 shrimp, 1 crab, 1 squid, 1 crayfish, 1 oyster, and 1 scad) were surveillance samples. All were collected from May 20, 2025 to September 25, 2025.
The samples were imported from 25 unique firms in 9 countries. Each sample consisted of 48 subsamples (i.e., individual packaged frozen seafood products randomly collected from the same lot). FDA field personnel collected the samples in import status, which refers to products collected at ports of entry or other locations where they are held prior to being released into U.S. commerce.
FDA laboratories evaluated the samples’ net weight using the Association of Official Analytical Chemists (AOAC) method 963.18 – “Net Contents of Frozen Seafoods – Drained Weight Procedure.” Samples showing an average short weight of 1% or more below the declared net weight were referred to FDA compliance for evaluation and potential regulatory actions (see FDA’s Compliance Policy Guide Sec 562.300 Foods – Net Weight).
Findings
Of the 26 samples collected and tested, the FDA found 12 (46%) to be violative, with the percentage of short weight in individual samples ranging from 1.42% to 32.75%. The violative samples were imported from 11 unique firms in six countries and included a variety of seafood products (crab, oyster, shrimp, squid, and scad).
A breakdown of the violative sample findings by country of origin is provided in Table 1. The FDA cautions against making inferences based solely on these test results by country of origin because the agency did not design the assignment for such comparison.
Table 1: Violative Samples by Country of Origin
| Country of Origin | No. of Samples Tested | No. Violative | Product Type |
| Canada | 1 | 1 | Crab |
| China | 2 | 1 | Squid |
| India | 9 | 2 | Shrimp |
| Indonesia | 3 | 3 | Shrimp |
| Korea (the Republic of) | 1 | 1 | Oyster |
| Vietnam | 4 | 4 | Shrimp (3), Scad (1) |
The highest levels of short weighting included a squid product from China (32.8 %), an oyster product from South Korea (20.4%), a shrimp product from Indonesia (10.2%) and a scad product from Vietnam (10.2%). The full data set for this assignment (i.e., all samples collected and tested, their country of origin, and compliance status) is provided in the Table of Analytical Results.
Follow-Up Actions
When the FDA detected a violation, the agency took follow-up regulatory action to prevent further distribution of adulterated and/or mislabeled products in U.S. commerce and precluded future shipments from the same firms until these firms made appropriate corrections.
All 12 violative samples resulted in refusal of entry for that shipment into the U.S. In addition, the agency placed the associated 114 firms and their violative products on Import Alert 99-47, “Detention Without Physical Examination of Human Food Products That Appear to be Adulterated for Economic Gain.” Products listed on IA 99-47 are subject to Detention Without Physical Examination (DWPE), an enforcement tool that allows the FDA to detain products at ports of entry without inspecting or sampling the shipment. For those products to be admitted into the U.S., the firm must provide evidence to the agency that overcomes the appearance of the violation, such as the test results of a third-party laboratory, verifying that the product has not been short weighted.
Discussion
The FDA’s assignments conducted in 2022–2024 and 2025 to identify short weighting in frozen imported seafood found violation rates of 36% and 46%, respectively. These findings indicate that imported frozen seafood products remain a target for economic adulteration and reaffirm the need for the agency to continue to address the matter to ensure that consumers are not deceived and receive a fair value for their purchase. Accordingly, the agency will continue to monitor imported frozen seafood products for short weighting, prioritizing the sampling of products based on risk.
Samples violative for short weighting are subject to enforcement action, consistent with the FDA’s mission to ensure that food is safe, wholesome, and properly labeled. When appropriate, the FDA may consider pursuing criminal investigations. The agency also collaborates with international counterparts to detect and combat economic adulteration related to imported products, including imported frozen seafood. Firms that import frozen seafood and domestic firms that produce frozen seafood can help protect consumers by ensuring that the net weight of their products meets the net weight declared on the label, excluding the glaze, as required by the FD&C Act.
Table of Analytical Results
The table that follows is organized alphabetically by sample country of origin. The dashes indicate samples in compliance.
| Sample No. | Firm | Country of Origin | Product | % Short Weight |
|---|---|---|---|---|
| 1 | A | Canada | Crab | 3.47% (Violative) a |
| 2 | B | China | Shrimp | — |
| 3 | C | China | Squid | 32.75% (Violative) |
| 4 | D | Ecuador | Shrimp | — |
| 5 | E | Ecuador | Shrimp | — |
| 6 | F | Ecuador | Shrimp | — |
| 7 | G | Ecuador | Shrimp | — |
| 8 | H | Egypt | Crayfish | — |
| 9 | I | India | Shrimp | — |
| 10 | J | India | Shrimp | — |
| 11 | K | India | Shrimp | — |
| 12 | L | India | Shrimp | — |
| 13 | M | India | Shrimp | — |
| 14 | N | India | Shrimp | — |
| 15 | O | India | Shrimp | — |
| 16 | P | India | Shrimp | 3.44% (Violative) |
| 17 | Q | India | Shrimp | 8.39% (Violative) |
| 18 | R | Indonesia | Shrimp | 1.84% (Violative) |
| 19 | S | Indonesia | Shrimp | 5.91% (Violative) |
| 20 | S | Indonesia | Shrimp | 10.18% (Violative) |
| 21 | T | Korea (Republic of) | Oysters | 20.44% (Violative) |
| 22 | U | Peru | Shrimp | — |
| 23 | V | Vietnam | Shrimp | 4.30% (Violative) |
| 24 | W | Vietnam | Shrimp | 1.58% (Violative) |
| 25 | X | Vietnam | Scad | 10.19% (Violative) |
| 26 | Y | Vietnam | Shrimp | 1.42% (Violative) |
a. "Violative" refers to samples found to be short weighted by more than 1% below the declared net weight. The FDA refused entry to the shipments associated with violative samples and placed implicated firms and their products on Import Alert 99-47.
Related Resources
- FDA Continues Fight Against Fraud in Imported Seafood (Infographic, PDF)
- 1Ice glaze is a thin protective layer of ice that is applied to frozen seafood after processing and freezing.
- 2Section 402(b) of the FD&C Act prohibits the adulteration of food by adding any substance (such as ice glaze) to increase its bulk or weight. Section 403(e)(2) of the FD&C Act and section 4(a)(2) of the Fair Packaging and Labeling Act require food to bear an accurate statement of the net quantity of contents. Overstating the net quantity of contents misbrands products under these sections.
- 3Targeting is the process of strategically selecting and testing samples that may be more likely to contain violations based on complaints received or other information
- 4One firm was responsible for 2 of the 12 violative samples.